Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Relmada Therapeutics Appoints Bipin Dalmia As Chief Business Officer
PUBLIC · RLMDJul 28, 2026•12 days ago
Position
Chief Business Officer
Company
RELMADA THERAPEUTICS, INC.
New YorkBiotechnologyDescription
Bipin Dalmia joins Relmada Therapeutics to advance the development of NDV-01, a novel therapy for NMIBC. His extensive experience in biopharmaceutical leadership will contribute to the company's growth and innovation in this area.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months